CID 9915372

Uk-224671

Structural Information

Molecular Formula
C24H35Cl2N5O3S
SMILES
C1CC1CN2C[C@@](CCC2=O)(CCN3CC(C3)N4CCN(CC4)S(=O)(=O)N)C5=CC(=C(C=C5)Cl)Cl
InChI
InChI=1S/C24H35Cl2N5O3S/c25-21-4-3-19(13-22(21)26)24(6-5-23(32)30(17-24)14-18-1-2-18)7-8-28-15-20(16-28)29-9-11-31(12-10-29)35(27,33)34/h3-4,13,18,20H,1-2,5-12,14-17H2,(H2,27,33,34)/t24-/m1/s1
InChIKey
OQXJUJDDCWHRLA-XMMPIXPASA-N
Compound name
4-[1-[2-[(3S)-1-(cyclopropylmethyl)-3-(3,4-dichlorophenyl)-6-oxopiperidin-3-yl]ethyl]azetidin-3-yl]piperazine-1-sulfonamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

7
References

138
Patents

543.1838 Da
Monoisotopic Mass

2.2
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 544.19108 213.2
[M+Na]+ 566.17302 221.7
[M+NH4]+ 561.21762 216.7
[M+K]+ 582.14696 214.8
[M-H]- 542.17652 221.6
[M+Na-2H]- 564.15847 219.7
[M]+ 543.18325 217.6
[M]- 543.18435 217.6
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe